 |
市場調查報告書
商品編碼
2052714
mRNA合成服務市場：按應用、企業規模、最終用戶和地區分類M-RNA Synthesis Service Market, By Application, By Scale of Operation, By End User, By Geography |
||||||
據估計，2026年mRNA合成服務市場規模為75.904億美元，預計2033年將達到112.409億美元。預計2026年至2033年，該市場將以5.8%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 75.904億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 5.80% | 2033年市場規模預測： | 112.409億美元 |
以DNA為模板合成傳訊RNA（mRNA）的過程稱為轉錄。 mRNA攜帶來自細胞核內染色體DNA的遺傳訊息到達細胞質表面。 mRNA是一種用途廣泛的工具，可用於基因編輯、細胞治療、疫苗和治療性蛋白質替代等許多領域。它能夠透過mRNA導入任何蛋白質，從而實現基因編輯工具和抗原的細胞內生產。
mRNA是與基因DNA鏈互補的單股RNA分子。合成mRNA用於研究蛋白質介導的mRNA辨識、細胞外mRNA的運輸和翻譯，以及突變對蛋白質編碼基因的影響。近年來，基於mRNA的藥物已被開發用於治療多種疾病，包括呼吸系統疾病、心臟病、自體免疫疾病、自體免疫疾病以及癌症、癌症免疫療法和預防性疫苗。
市場動態
預計在預測期內，市場參與者之間併購活動的增加將推動市場成長。例如，2022年1月，為研究人員和生物技術創新者提供生命科學試劑和服務的全球性公司Maravai LifeSciences, Inc.宣布以2.4億美元收購MyChem, LLC，後者是一家專門生產超高純度核苷酸的公司。此次收購將擴大Maravai在快速成長的mRNA治療和疫苗應用市場中的策略性原料產品線。
預計在預測期內，市場成長將主要受mRNA合成技術投資增加的推動，因為市場主要參與者正在擴展產品系列。例如，2022年12月，金融公司Direxion宣布推出新的交易所交易基金（ETF）—“Direxion mRNA ETF”，該基金專注於傳訊RNA技術的應用和開發。該基金旨在投資於正在開發和應用mRNA技術的公司。
本次調查的主要特點
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本研究基於以下參數，對全球mRNA合成服務市場的主要參與者進行了概況分析：公司亮點、產品系列、關鍵特性、財務績效和策略。本研究涵蓋的主要參與者包括：Maravai LifeSciences、Azenta US, Inc.、Creative Biolabs、Becton, Dickinson And Company、Creative Biogene、Kaneka Corporation、Danaher、eTheRNA、Biomay AG、ApexBio Technology、RiboPro、F. Hoffmann-La Roche. Biosciences、Aldevron和GenScript。
- 本報告中的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 全球 mRNA 合成服務市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過對全球 mRNA 合成服務市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場吸引力分析
- 市場機遇
- 產品發布
- 併購和合作
- 監管準則與合規性
- 主要進展
- PEST分析
- 科技趨勢
- 服務成本分析
第4章 全球mRNA合成服務市場：依應用領域分類，2021-2033年
- 藥物研發
- 疫苗生產
- 藥物發現
- 其他
第5章 全球mRNA合成服務市場：依企業規模分類，2021-2033年
- 調查
- 商業
第6章 全球mRNA合成服務市場：依最終用戶分類，2021-2033年
- 生物製藥公司
- 受託研究機構（CRO）
- 其他
第7章 全球mRNA合成服務市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第8章 競爭情勢
- Maravai LifeSciences
- Azenta US, Inc.
- Creative Biolabs
- Becton, Dickinson And Company
- Creative Biogene
- Kaneka Corporation
- Danaher
- eTheRNA
- Biomay AG
- ApexBio Technology
- RiboPro
- F. Hoffmann-La Roche Ltd.
- System Biosciences, LLC
- Aurigene Pharmaceutical Services Ltd.
- OZ Biosciences
- Aldevron
- GenScript
第9章
- 調查方法
- 關於本公司
m-RNA Synthesis Service Market is estimated to be valued at USD 7,590.4 Mn in 2026 and is expected to reach USD 11,240.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7,590.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 11,240.9 Mn |
Messenger RNA (MRNA) synthesis, using DNA as the template, is called transcription. The MRNA carries the genetic information from the chromosomes' DNA in the nucleus to the surface of the cytosol. MRNA is a flexible tool that is utilized for gene editing, cell therapy, vaccinations, and therapeutic protein replacement, among other . The ability to introduce any protein via MRNA enables the cellular production of gene editing tools or antigens.
MRNA is a single-stranded RNA molecule that is complementary to one of a gene's DNA strands. Synthetic MRNAs are used to investigate protein-mediated MRNA recognition, MRNA export and translation, and mutation effects on protein-coding genes. Recently, MRNA-based medicines have been developed for the treatment of various diseases including respiratory, cardiac, metabolic and autoimmune diseases, as well as cancer, cancer immunotherapy, and preventive vaccinations.
Market Dynamics
Increasing number of acquisitions between market players is expected to drive the market growth over the forecast period. For instance, in January 2022, Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, announced that it has acquired MyChem, LLC, company focused on making ultra-pure nucleotides, for US$ 240 million. This acquisition will expand Maravai's product offering of strategic inputs in the rapidly growing markets for MRNA therapeutics and vaccine applications.
Increasing investments for M-RNA based technologies for M-RNA synthesis by the key players in the market in order to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Direxion, a financial corporation, announced the launch of the Direxion MRNA ETF, a new exchange-traded fund (ETF) that focuses on the applications and developments of messenger RNA technology. This fund seeks to invest in firms that are developing and applying MRNA technology.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global M-RNA synthesis service market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company, Creative Biogene, Kaneka Corporation, Danaher, eTheRNA, Biomay AG, ApexBio Technology, RiboPro, F. Hoffmann-La Roche Ltd, System Biosciences, LLC., Aurigene Pharmaceutical Services Ltd., OZ Biosciences, Aldevron and GenScript.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global M-RNA synthesis service market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global M-RNA synthesis service market.
Market Segmentation
- Global M-RNA Synthesis Service Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Therapeutic Development
- Vaccine Production
- Drug Discovery
- Others
- Global M-RNA Synthesis Service Market, By Scale of Operation (Revenue, USD Mn, 2021 - 2033)
- Research
- Commercial
- Global M-RNA Synthesis Service Market By End User
- Biopharmaceutical Companies
- Contract research organizations (CROs)
- Others
- Global M-RNA Synthesis Service Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Country/Region
- Company Profiles
- Maravai LifeSciences
- Azenta US, Inc.
- Creative Biolabs
- Becton, Dickinson And Company
- Creative Biogene
- Kaneka Corporation
- Danaher
- eTheRNA
- Biomay AG
- ApexBio Technology
- RiboPro
- F. Hoffmann-La Roche Ltd.
- System Biosciences, LLC
- Aurigene Pharmaceutical Services Ltd.
- OZ Biosciences
- Aldevron
- GenScript
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Scale of Operation
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- Service Cost Analysis
4. Global M-RNA Synthesis Service Market , By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Therapeutic Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaccine Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global M-RNA Synthesis Service Market , By Scale of Operation, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Commercial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global M-RNA Synthesis Service Market , By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global M-RNA Synthesis Service Market , By Region, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Maravai LifeSciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Azenta US, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson And Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative Biogene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kaneka Corporation
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher
- Company Highlights
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- eTheRNA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomay AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ApexBio Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RiboPro
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- System Biosciences, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aurigene Pharmaceutical Services Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OZ Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aldevron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
